Chemo regimen can limit Herceptin heart risk-study (Reuters)
8th Dec 2005, 16:14 GMT
Reuters - The breast cancer drug Herceptin, shown recently to improve survival in women with early-stage breast cancer, carries with it a risk of heart damage, but a chemotherapy regimen can limit the danger, researchers said on Thursday.
Chemo regimen can limit Herceptin heart risk-study (Reuters) related news:
- Chemo regimen can limit Herceptin heart risk-study — Reuters: Health
- Interim Analysis of Phase III Study Shows TAXOTERE Based Regimens With HERCEPTIN Significantly Improved Disease Free Survival in Women With Early-Stage HER2-Positive Breast Cancer — Mammography News from StratCenter.com
- HERCEPTIN 'CUTS RISK' OF CANCER — Mirror.co.uk - News - Top Stories
- Breast cancer drug halves return risk — the Mail online | Health
- Fiber in diet doesn't cut colon cancer risk -study (Reuters) — Yahoo! News: Health News
- Fiber in diet doesn't cut colon cancer risk -study — Reuters: Health
- Dose-Dense Adjuvant Chemo Regimen Safe, More Effective for Selected Breast Cancer Patients — Medscape Medical News Headlines
- Study to test safety of Celebrex, other pain relievers, for heart patients — Vail Daily - Top Stories
- Chemo after surgery extends life in endometrial cancer (Reuters) — Yahoo! News: Health News
- SABCS: Shorter Chemotherapy Regimen Plus Taxol Reduces Breast Cancer Recurrence — MedPage Today Hematology/Oncology
Latest news from Yahoo! News: Health News:
- Health care costs could jump 10 percent (AP)
- Results mixed on Merck's new painkiller (AP)
- More South Africans get AIDS medicine (AP)
- Europe to draw up strategy against obesity (AFP)
- Clinical Trials Update: Nov. 13, 2006 (HealthDay)
- Pharmacy Program Helps Elderly Take Their Meds (HealthDay)
- Red meat may raise breast cancer risk (AP)
- Insurers' plan aims to cover uninsured (AP)
- FDA: Tamiflu patients need monitoring (AP)
- Flu Drug Tamiflu May Cause Odd Behavior in Children (HealthDay)